Delivery Order 75N93021D00014-75N93022F00001
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $358,854 delivery order against its Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity contract to Colorado State University Sponsored Programs Division. The delivery order is for testing standard drugs for Mycobacterium tuberculosis in animal models to support the agency's preclinical services program. Work will be performed by Colorado State University in...
- This federal contract award, valued at $1,353,907, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Colorado State University's Sponsored Programs division. The purpose of the award is to conduct "Antimycobacterial Evaluation of Chemical Entities in Mouse Models." This task order falls under NIAID's larger "Animal Models of Infectious Diseases 2010-2017" IDIQ contract. The award does not have a set-aside designation. Colorado State University...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Colorado State University (CSU) for the development of "Advanced Small Animal Models for the Testing of Candidate Preventive Intervention Against Mycobacteria." The award, valued at $3,086,647, is a task order under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery/indefinite quantity (IDIQ)...
- This is a delivery order task award under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery, indefinite-quantity (IDIQ) contract. The $2,065,203.31 task order was awarded to Colorado State University (CSU) to provide advanced small animal models for testing candidate preventive interventions against Mycobacterium tuberculosis. The work will be performed in Fort Collins, Colorado. This award is not set aside...
- This delivery order from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $14,945.99 to Colorado State University Sponsored Programs Division for work to be conducted from April to August 2021. The task order is issued against the Preclinical Services for HIV Therapeutics indefinite-delivery/indefinite-quantity contract vehicle and requires development and delivery of a quality...
- This is a $1,272,402.60 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Colorado State University for preclinical models of infectious diseases research. The award is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a firm-fixed price structure and an ultimate completion date of August 2, 2025. Colorado State University, a public land-grant research...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Colorado State University (CSU) for the collection of metadata from in vivo studies performed under previous indefinite-delivery, indefinite-quantity (IDIQ) contract mechanisms. The contract has a ceiling value of $56,795.00 and runs through July 14, 2031. The contract does not have a set-aside designation. CSU's Sponsored Programs division, which has provided a...
- This federal contract award is for an indefinite delivery/indefinite quantity (IDIQ) contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Colorado State University (CSU) for animal models of infectious diseases research and services. The contract has a ceiling value of $1,192,484.45 and a period of performance through March 21, 2017. The contract is a delivery order under the broader NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ. CSU, through its Sponsored...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.28 million delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract to Colorado State University Sponsored Programs Division. Colorado State University Sponsored Programs Division will perform Task A07 under the delivery order as the prime contractor. The work will be conducted in Fort...
- This federal contract award is for an in vitro assessment of antimicrobial activity, with a potential value of $106,534.00. The contract was awarded on September 8, 2017 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Colorado State University's Sponsored Programs division. The contract is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract...
- Preclinical Services for HIV TherapeuticsMaster IDIQ
- 75N93021D00014Indefinite Delivery Contract
- 75N93021D00014-75N93022F00001Delivery Order
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Colorado State University to conduct testing of drug combinations for Mycobacterium tuberculosis (MTB) in mice. The $1,457,348.00 contract is a delivery order under NIAID's Preclinical Services for HIV Therapeutics master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation. Colorado State University is the prime contractor, and the University of Colorado-Denver is a subcontractor. The purpose is to test standard MTB combination drugs in a small animal model. This work supports NIAID's broader mission in preclinical services for the development of HIV therapeutics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Change Order | $207.0k | 9/10/24 | |
| P00001 | Other Administrative Action | $0 | 11/9/23 | |
| Not listed | Not listed | $1.3m | 8/29/22 |